{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:43:32Z","timestamp":1790257412459,"version":"4.1.0"},"reference-count":91,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T00:00:00Z","timestamp":1598400000000},"content-version":"vor","delay-in-days":1274,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001593","name":"Irish Cancer Society","doi-asserted-by":"publisher","award":["CCRC13GAL"],"award-info":[{"award-number":["CCRC13GAL"]}],"id":[{"id":"10.13039\/501100001593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["15\/IA\/3104"],"award-info":[{"award-number":["15\/IA\/3104"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1074\/jbc.r116.755694","type":"journal-article","created":{"date-parts":[[2017,2,2]],"date-time":"2017-02-02T02:00:18Z","timestamp":1486000818000},"page":"3543-3551","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["The Emerging Role of Non-traditional Ubiquitination in Oncogenic Pathways"],"prefix":"10.1016","volume":"292","author":[{"given":"Lisa","family":"Dwane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William M.","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tr\u00edona","family":"N\u00ed Chonghaile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darran P.","family":"O'Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.R116.755694_bib1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/cr.2013.151","article-title":"Protein post-translational modifications and regulation of pluripotency in human stem cells","volume":"24","author":"Wang","year":"2014","journal-title":"Cell Res"},{"key":"10.1074\/jbc.R116.755694_bib2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev.biochem.67.1.425","article-title":"The ubiquitin system","volume":"67","author":"Hershko","year":"1998","journal-title":"Annu. Rev. Biochem"},{"key":"10.1074\/jbc.R116.755694_bib3","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1096\/fasebj.11.14.9409544","article-title":"Pathways of ubiquitin conjugation","volume":"11","author":"Haas","year":"1997","journal-title":"FASEB J"},{"key":"10.1074\/jbc.R116.755694_bib4","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO;2-Q","article-title":"Ubiquitin-mediated proteolysis: biological regulation via destruction","volume":"22","author":"Ciechanover","year":"2000","journal-title":"Bioessays"},{"key":"10.1074\/jbc.R116.755694_bib5","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.tcb.2004.01.004","article-title":"N-terminal ubiquitination: more protein substrates join in","volume":"14","author":"Ciechanover","year":"2004","journal-title":"Trends Cell Biol"},{"key":"10.1074\/jbc.R116.755694_bib6","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1242\/jcs.093567","article-title":"Non-canonical ubiquitin-based signals for proteasomal degradation","volume":"125","author":"Kravtsova-Ivantsiv","year":"2012","journal-title":"J. Cell Sci"},{"key":"10.1074\/jbc.R116.755694_bib7","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1126\/science.1110340","article-title":"Ubiquitination on nonlysine residues by a viral E3 ubiquitin ligase","volume":"309","author":"Cadwell","year":"2005","journal-title":"Science"},{"key":"10.1074\/jbc.R116.755694_bib8","doi-asserted-by":"crossref","first-page":"674","DOI":"10.3390\/cells3030674","article-title":"Mechanisms of generating polyubiquitin chains of different topology","volume":"3","author":"Suryadinata","year":"2014","journal-title":"Cells"},{"key":"10.1074\/jbc.R116.755694_bib9","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev.biochem.70.1.503","article-title":"Mechanisms underlying ubiquitination","volume":"70","author":"Pickart","year":"2001","journal-title":"Annu. Rev. Biochem"},{"key":"10.1074\/jbc.R116.755694_bib10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbamcr.2004.09.019","article-title":"Ubiquitin: structures, functions, mechanisms","volume":"1695","author":"Pickart","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/jbc.R116.755694_bib11","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.tibs.2003.09.005","article-title":"Distinct monoubiquitin signals in receptor endocytosis","volume":"28","author":"Haglund","year":"2003","journal-title":"Trends Biochem. Sci"},{"key":"10.1074\/jbc.R116.755694_bib12","doi-asserted-by":"crossref","first-page":"T19","DOI":"10.1530\/ERC-14-0185","article-title":"Histone H2B monoubiquitination: roles to play in human malignancy","volume":"22","author":"Cole","year":"2015","journal-title":"Endocr.-Relat. Cancer"},{"key":"10.1074\/jbc.R116.755694_bib13","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1083\/jcb.200908074","article-title":"The ubiquitin landscape at DNA double-strand breaks","volume":"187","author":"Messick","year":"2009","journal-title":"J. Cell Biol"},{"key":"10.1074\/jbc.R116.755694_bib14","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.3390\/cells3041027","article-title":"Versatile roles of K63-linked ubiquitin chains in trafficking","volume":"3","author":"Erpapazoglou","year":"2014","journal-title":"Cells"},{"key":"10.1074\/jbc.R116.755694_bib15","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1146\/annurev.immunol.021908.132641","article-title":"Regulation and function of NF-\u03baB transcription factors in the immune system","volume":"27","author":"Vallabhapurapu","year":"2009","journal-title":"Annu. Rev. Immunol"},{"key":"10.1074\/jbc.R116.755694_bib16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/fonc.2012.00005","article-title":"K63-linked ubiquitination in kinase activation and cancer","volume":"2","author":"Wang","year":"2012","journal-title":"Front. Oncol"},{"key":"10.1074\/jbc.R116.755694_bib17","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1128\/MCB.15.3.1265","article-title":"A ubiquitin mutant with specific defects in DNA repair and multiubiquitination","volume":"15","author":"Spence","year":"1995","journal-title":"Mol. Cell. Biol"},{"key":"10.1074\/jbc.R116.755694_bib18","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0022-2836(02)01198-1","article-title":"Structural properties of polyubiquitin chains in solution","volume":"324","author":"Varadan","year":"2002","journal-title":"J. Mol. Biol"},{"key":"10.1074\/jbc.R116.755694_bib19","doi-asserted-by":"crossref","first-page":"7055","DOI":"10.1074\/jbc.M309184200","article-title":"Solution conformation of Lys63-linked di-ubiquitin chain provides clues to functional diversity of polyubiquitin signaling","volume":"279","author":"Varadan","year":"2004","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.R116.755694_bib20","doi-asserted-by":"crossref","first-page":"34743","DOI":"10.1074\/jbc.C300249200","article-title":"The BRCA1\/BARD1 heterodimer assembles polyubiquitin chains through an unconventional linkage involving lysine residue K6 of ubiquitin","volume":"278","author":"Wu-Baer","year":"2003","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.R116.755694_bib21","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nsmb1295","article-title":"E2-BRCA1 RING interactions dictate synthesis of mono- or specific polyubiquitin chain linkages","volume":"14","author":"Christensen","year":"2007","journal-title":"Nat. Struct. Mol. Biol"},{"key":"10.1074\/jbc.R116.755694_bib22","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1182\/blood-2012-04-403733","article-title":"Proteasome inhibitors in multiple myeloma: 10 years later","volume":"120","author":"Moreau","year":"2012","journal-title":"Blood"},{"key":"10.1074\/jbc.R116.755694_bib23","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1081\/CNV-120030223","article-title":"\u201cDevelopment of the proteasome inhibitor Velcade (Bortezomib)\u201d by Julian Adams, Ph.D., and Michael Kauffman, M.D., Ph.D","volume":"22","author":"Bold","year":"2004","journal-title":"Cancer Invest"},{"key":"10.1074\/jbc.R116.755694_bib24","first-page":"5","article-title":"Development of proteasome inhibitors as therapeutic drugs","volume":"S5","author":"Pellom","year":"2012","journal-title":"J. Clin. Cell. Immunol"},{"key":"10.1074\/jbc.R116.755694_bib25","first-page":"237","article-title":"Carfilzomib: a novel treatment in relapsed and refractory multiple myeloma","volume":"5","author":"Fostier","year":"2012","journal-title":"Onco Targets Ther"},{"key":"10.1074\/jbc.R116.755694_bib26","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1056\/NEJMoa1516282","article-title":"Oral Ixazomib, Lenalidomide, and Dexamethasone for multiple myeloma","volume":"374","author":"Moreau","year":"2016","journal-title":"N. Engl. J. Med"},{"key":"10.1074\/jbc.R116.755694_bib27","first-page":"589","article-title":"Histone modifications and cancer: biomarkers of prognosis?","volume":"2","author":"Chervona","year":"2012","journal-title":"Am. J. Cancer Res"},{"key":"10.1074\/jbc.R116.755694_bib28","doi-asserted-by":"crossref","first-page":"5739","DOI":"10.1158\/0008-5472.CAN-11-1896","article-title":"Estrogen-dependent gene transcription in human breast cancer cells relies upon proteasome-dependent monoubiquitination of histone H2B","volume":"71","author":"Prenzel","year":"2011","journal-title":"Cancer Res"},{"key":"10.1074\/jbc.R116.755694_bib29","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1210\/me.2004-0164","article-title":"Inhibiting proteasomal proteolysis sustains estrogen receptor-\u03b1 activation","volume":"18","author":"Fan","year":"2004","journal-title":"Mol. Endocrinol"},{"key":"10.1074\/jbc.R116.755694_bib30","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1158\/0008-5472.CAN-13-1960","article-title":"USP9X downregulation renders breast cancer cells resistant to tamoxifen","volume":"74","author":"Oosterkamp","year":"2014","journal-title":"Cancer Res"},{"key":"10.1074\/jbc.R116.755694_bib31","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3389\/fonc.2012.00026","article-title":"Histone ubiquitination and deubiquitination in transcription, DNA damage response, and cancer","volume":"2","author":"Cao","year":"2012","journal-title":"Front. Oncol"},{"key":"10.1074\/jbc.R116.755694_bib32","doi-asserted-by":"crossref","first-page":"e0133444","DOI":"10.1371\/journal.pone.0133444","article-title":"Microarray analysis reveals potential biological functions of histone H2B monoubiquitination","volume":"10","author":"Wu","year":"2015","journal-title":"PLoS One"},{"key":"10.1074\/jbc.R116.755694_bib33","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.humpath.2015.04.001","article-title":"Decreased H2B monoubiquitination and overexpression of ubiquitin-specific protease enzyme 22 in malignant colon carcinoma","volume":"46","author":"Wang","year":"2015","journal-title":"Hum. Pathol"},{"key":"10.1074\/jbc.R116.755694_bib34","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/hmg\/ddr490","article-title":"The tumor suppressor CDC73 interacts with the ring finger proteins RNF20 and RNF40 and is required for the maintenance of histone 2B monoubiquitination","volume":"21","author":"Hahn","year":"2012","journal-title":"Hum. Mol. Genet"},{"key":"10.1074\/jbc.R116.755694_bib35","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.celrep.2016.01.020","article-title":"RNF20 links histone H2B ubiquitylation with inflammation and inflammation-associated cancer","volume":"14","author":"Tarcic","year":"2016","journal-title":"Cell Rep"},{"key":"10.1074\/jbc.R116.755694_bib36","doi-asserted-by":"crossref","first-page":"12654","DOI":"10.18632\/oncotarget.3705","article-title":"High USP22 expression indicates poor prognosis in hepatocellular carcinoma","volume":"6","author":"Tang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1074\/jbc.R116.755694_bib37","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3390\/ijms16010307","article-title":"USP22 promotes NSCLC tumorigenesis via MDMX up-regulation and subsequent p53 inhibition","volume":"16","author":"Ding","year":"2014","journal-title":"Int. J. Mol. Sci"},{"key":"10.1074\/jbc.R116.755694_bib38","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.pharmthera.2014.11.002","article-title":"Deubiquitinase inhibition as a cancer therapeutic strategy","volume":"147","author":"D'Arcy","year":"2015","journal-title":"Pharmacol. Ther"},{"key":"10.1074\/jbc.R116.755694_bib39","doi-asserted-by":"crossref","first-page":"5875","DOI":"10.1038\/sj.onc.1209878","article-title":"Fanconi anaemia genes and susceptibility to cancer","volume":"25","author":"Mathew","year":"2006","journal-title":"Oncogene"},{"key":"10.1074\/jbc.R116.755694_bib40","doi-asserted-by":"crossref","first-page":"669","DOI":"10.14348\/molcells.2015.0175","article-title":"Exploiting the Fanconi anemia pathway for targeted anti-cancer therapy","volume":"38","author":"Jo","year":"2015","journal-title":"Mol. Cells"},{"key":"10.1074\/jbc.R116.755694_bib41","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.mrrev.2016.06.004","article-title":"The ubiquitin family meets the Fanconi anemia proteins","volume":"769","author":"Renaudin","year":"2016","journal-title":"Mutat. Res. Rev. Mutat. Res"},{"key":"10.1074\/jbc.R116.755694_bib42","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1044-579X(02)00102-5","article-title":"Regulation of the Fanconi anemia pathway by monoubiquitination","volume":"13","author":"Gregory","year":"2003","journal-title":"Semin. Cancer Biol"},{"key":"10.1074\/jbc.R116.755694_bib43","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.celrep.2015.06.014","article-title":"Deficiency of UBE2T, the E2 ubiquitin ligase necessary for FANCD2 and FANCI ubiquitination, causes FA-T Subtype of Fanconi anemia","volume":"12","author":"Rickman","year":"2015","journal-title":"Cell Rep"},{"key":"10.1074\/jbc.R116.755694_bib44","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.bbrc.2015.08.127","article-title":"Regulation of Fanconi anemia protein FANCD2 monoubiquitination by miR-302","volume":"466","author":"Suresh","year":"2015","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1074\/jbc.R116.755694_bib45","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/ncb2329","article-title":"The AMPK signalling pathway coordinates cell growth, autophagy and metabolism","volume":"13","author":"Mihaylova","year":"2011","journal-title":"Nat. Cell Biol"},{"key":"10.1074\/jbc.R116.755694_bib46","doi-asserted-by":"crossref","first-page":"53642","DOI":"10.18632\/oncotarget.10686","article-title":"AMP-activated protein kinase is involved in the activation of the Fanconi anemia\/BRCA pathway in response to DNA interstrand crosslinks","volume":"7","author":"Chun","year":"2016","journal-title":"Oncotarget"},{"key":"10.1074\/jbc.R116.755694_bib47","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.molcel.2005.01.008","article-title":"The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway","volume":"17","author":"Nijman","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1074\/jbc.R116.755694_bib48","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/1873-3468.12060","article-title":"The role of USP1 autocleavage in DNA interstrand crosslink repair","volume":"590","author":"Kim","year":"2016","journal-title":"FEBS Lett"},{"key":"10.1074\/jbc.R116.755694_bib49","doi-asserted-by":"crossref","first-page":"342","DOI":"10.4161\/15384101.2014.987614","article-title":"FANCD2, FANCJ and BRCA2 cooperate to promote replication fork recovery independently of the Fanconi Anemia core complex","volume":"14","author":"Raghunandan","year":"2015","journal-title":"Cell Cycle"},{"key":"10.1074\/jbc.R116.755694_bib50","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/jb\/mvr139","article-title":"Role of K63-linked polyubiquitination in NF-\u03baB signalling: which ligase catalyzes and what molecule is targeted?","volume":"151","author":"Hayakawa","year":"2012","journal-title":"J. Biochem"},{"key":"10.1074\/jbc.R116.755694_bib51","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.3390\/v6103925","article-title":"Regulation of HTLV-1 tax stability, cellular trafficking and NF-\u03baB activation by the ubiquitin-proteasome pathway","volume":"6","author":"Lavorgna","year":"2014","journal-title":"Viruses"},{"key":"10.1074\/jbc.R116.755694_bib52","doi-asserted-by":"crossref","first-page":"5798","DOI":"10.1038\/ncomms6798","article-title":"STAT3 restrains RANK- and TLR4-mediated signalling by suppressing expression of the E2 ubiquitin-conjugating enzyme Ubc13","volume":"5","author":"Zhang","year":"2014","journal-title":"Nat. Commun"},{"key":"10.1074\/jbc.R116.755694_bib53","doi-asserted-by":"crossref","first-page":"3964","DOI":"10.4161\/15384101.2014.988026","article-title":"Novel Lys63-linked ubiquitination of IKK\u03b2 induces STAT3 signaling","volume":"13","author":"Gallo","year":"2014","journal-title":"Cell Cycle"},{"key":"10.1074\/jbc.R116.755694_bib54","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.molcel.2008.05.014","article-title":"cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination","volume":"30","author":"Bertrand","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1074\/jbc.R116.755694_bib55","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.celrep.2015.03.012","article-title":"NF-\u03baB-activating complex engaged in response to EGFR oncogene inhibition drives tumor cell survival and residual disease in lung cancer","volume":"11","author":"Blakely","year":"2015","journal-title":"Cell Rep"},{"key":"10.1074\/jbc.R116.755694_bib56","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/path.4479","article-title":"Golgi phosphoprotein 3 (GOLPH3) promotes hepatocellular carcinoma cell aggressiveness by activating the NF-\u03baB pathway","volume":"235","author":"Dai","year":"2015","journal-title":"J. Pathol"},{"key":"10.1074\/jbc.R116.755694_bib57","doi-asserted-by":"crossref","first-page":"e1004458","DOI":"10.1371\/journal.ppat.1004458","article-title":"HTLV-1 tax stabilizes MCL-1 via TRAF6-dependent K63-linked polyubiquitination to promote cell survival and transformation","volume":"10","author":"Choi","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1074\/jbc.R116.755694_bib58","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1172\/JCI75821","article-title":"Inhibition of IRAK1\/4 sensitizes T cell acute lymphoblastic leukemia to chemotherapies","volume":"125","author":"Li","year":"2015","journal-title":"J. Clin. Invest"},{"key":"10.1074\/jbc.R116.755694_bib59","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.biocel.2014.04.010","article-title":"TRAF6 is upregulated in colon cancer and promotes proliferation of colon cancer cells","volume":"53","author":"Sun","year":"2014","journal-title":"Int. J. Biochem. Cell Biol"},{"key":"10.1074\/jbc.R116.755694_bib60","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.3892\/or.2016.4602","article-title":"siRNA-induced TRAF6 knockdown promotes the apoptosis and inhibits the invasion of human lung cancer SPC-A1 cells","volume":"35","author":"He","year":"2016","journal-title":"Oncol. Rep"},{"key":"10.1074\/jbc.R116.755694_bib61","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/onc.2013.543","article-title":"TRAF2 is an NF-\u03baB-activating oncogene in epithelial cancers","volume":"34","author":"Shen","year":"2015","journal-title":"Oncogene"},{"key":"10.1074\/jbc.R116.755694_bib62","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nature01802","article-title":"The tumour suppressor CYLD negatively regulates NF-\u03baB signalling by deubiquitination","volume":"424","author":"Kovalenko","year":"2003","journal-title":"Nature"},{"key":"10.1074\/jbc.R116.755694_bib63","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nature01811","article-title":"Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-\u03baB","volume":"424","author":"Brummelkamp","year":"2003","journal-title":"Nature"},{"key":"10.1074\/jbc.R116.755694_bib64","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/nature02794","article-title":"De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-\u03baB signalling","volume":"430","author":"Wertz","year":"2004","journal-title":"Nature"},{"key":"10.1074\/jbc.R116.755694_bib65","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nrc2775","article-title":"A20: from ubiquitin editing to tumour suppression","volume":"10","author":"Hymowitz","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1074\/jbc.R116.755694_bib66","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/ijc.26124","article-title":"An RNAi screen identifies USP2 as a factor required for TNF-\u03b1-induced NF-\u03baB signaling","volume":"129","author":"Metzig","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1074\/jbc.R116.755694_bib67","doi-asserted-by":"crossref","first-page":"7391","DOI":"10.1038\/sj.onc.1209100","article-title":"AKT signaling in normal and malignant cells","volume":"24","author":"Testa","year":"2005","journal-title":"Oncogene"},{"key":"10.1074\/jbc.R116.755694_bib68","doi-asserted-by":"crossref","first-page":"7455","DOI":"10.1038\/sj.onc.1209085","article-title":"Perturbations of the AKT signaling pathway in human cancer","volume":"24","author":"Altomare","year":"2005","journal-title":"Oncogene"},{"key":"10.1074\/jbc.R116.755694_bib69","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/2045-3701-4-59","article-title":"Posttranslational regulation of Akt in human cancer","volume":"4","author":"Chan","year":"2014","journal-title":"Cell Biosci"},{"key":"10.1074\/jbc.R116.755694_bib70","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nature05933","article-title":"A transforming mutation in the pleckstrin homology domain of AKT1 in cancer","volume":"448","author":"Carpten","year":"2007","journal-title":"Nature"},{"key":"10.1074\/jbc.R116.755694_bib71","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1126\/science.1175065","article-title":"The E3 ligase TRAF6 regulates Akt ubiquitination and activation","volume":"325","author":"Yang","year":"2009","journal-title":"Science"},{"key":"10.1074\/jbc.R116.755694_bib72","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.cell.2012.02.065","article-title":"The Skp2-SCF E3 ligase regulates Akt ubiquitination, glycolysis, herceptin sensitivity, and tumorigenesis","volume":"149","author":"Chan","year":"2012","journal-title":"Cell"},{"key":"10.1074\/jbc.R116.755694_bib73","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.tcb.2011.08.008","article-title":"K11-linked ubiquitin chains as novel regulators of cell division","volume":"21","author":"Wickliffe","year":"2011","journal-title":"Trends Cell Biol"},{"key":"10.1074\/jbc.R116.755694_bib74","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1042\/BJ20080067","article-title":"Control of AMPK-related kinases by USP9X and atypical Lys29\/Lys33-linked polyubiquitin chains","volume":"411","author":"Al-Hakim","year":"2008","journal-title":"Biochem. J"},{"key":"10.1074\/jbc.R116.755694_bib75","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/hmg\/ddh095","article-title":"BRCA1: BARD1 induces the formation of conjugated ubiquitin structures, dependent on K6 of ubiquitin, in cells during DNA replication and repair","volume":"13","author":"Morris","year":"2004","journal-title":"Hum. Mol. Genet"},{"key":"10.1074\/jbc.R116.755694_bib76","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.1128\/MCB.23.14.5056-5063.2003","article-title":"Loss of Bard1, the heterodimeric partner of the Brca1 tumor suppressor, results in early embryonic lethality and chromosomal instability","volume":"23","author":"McCarthy","year":"2003","journal-title":"Mol. Cell. Biol"},{"key":"10.1074\/jbc.R116.755694_bib77","doi-asserted-by":"crossref","first-page":"14537","DOI":"10.1074\/jbc.C000881200","article-title":"The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation","volume":"276","author":"Hashizume","year":"2001","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.R116.755694_bib78","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.molcel.2015.05.006","article-title":"Quantitative proteomic atlas of ubiquitination and acetylation in the DNA damage response","volume":"59","author":"Elia","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1074\/jbc.R116.755694_bib79","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.celrep.2014.12.021","article-title":"RNF168 promotes noncanonical K27 ubiquitination to signal DNA damage","volume":"10","author":"Gatti","year":"2015","journal-title":"Cell Rep"},{"key":"10.1074\/jbc.R116.755694_bib80","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1517\/14728222.2013.815728","article-title":"Targeting the ubiquitin-proteasome system for cancer therapy","volume":"17","author":"Shen","year":"2013","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1074\/jbc.R116.755694_bib81","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1517\/13543776.2015.1056737","article-title":"Deubiquitinases (DUBs) and DUB inhibitors: a patent review","volume":"25","author":"Farshi","year":"2015","journal-title":"Expert Opin. Ther. Pat"},{"key":"10.1074\/jbc.R116.755694_bib82","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1080\/15384047.2014.1002358","article-title":"USP9X inhibition promotes radiation-induced apoptosis in non-small cell lung cancer cells expressing mid-to-high MCL1","volume":"16","author":"Kushwaha","year":"2015","journal-title":"Cancer Biol. Ther"},{"key":"10.1074\/jbc.R116.755694_bib83","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1158\/1535-7163.MCT-09-0097","article-title":"Small-molecule inhibitor of USP7\/HAUSP ubiquitin protease stabilizes and activates p53 in cells","volume":"8","author":"Colland","year":"2009","journal-title":"Mol. Cancer Ther"},{"key":"10.1074\/jbc.R116.755694_bib84","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1096\/fasebj.11.13.9367341","article-title":"Targeting of substrates to the 26S proteasome","volume":"11","author":"Pickart","year":"1997","journal-title":"FASEB J"},{"key":"10.1074\/jbc.R116.755694_bib85","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cell.2009.01.041","article-title":"Quantitative proteomics reveals the function of unconventional ubiquitin chains in proteasomal degradation","volume":"137","author":"Xu","year":"2009","journal-title":"Cell"},{"key":"10.1074\/jbc.R116.755694_bib86","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1083\/jcb.200810114","article-title":"K63-linked ubiquitin chains as a specific signal for protein sorting into the multivesicular body pathway","volume":"185","author":"Lauwers","year":"2009","journal-title":"J. Cell Biol"},{"key":"10.1074\/jbc.R116.755694_bib87","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nsmb.2955","article-title":"K63 polyubiquitination is a new modulator of the oxidative stress response","volume":"22","author":"Silva","year":"2015","journal-title":"Nat. Struct. Mol. Biol"},{"key":"10.1074\/jbc.R116.755694_bib88","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/ncb2012","article-title":"PINK1\/Parkin-mediated mitophagy is dependent on VDAC1 and p62\/SQSTM1","volume":"12","author":"Geisler","year":"2010","journal-title":"Nat. Cell Biol"},{"key":"10.1074\/jbc.R116.755694_bib89","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/sj.embor.7400822","article-title":"Itch\/AIP4 mediates Deltex degradation through the formation of K29-linked polyubiquitin chains","volume":"7","author":"Chastagner","year":"2006","journal-title":"EMBO Rep"},{"key":"10.1074\/jbc.R116.755694_bib90","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.molcel.2006.02.011","article-title":"Differential modification of Ras proteins by ubiquitination","volume":"21","author":"Jura","year":"2006","journal-title":"Mol. Cell"},{"key":"10.1074\/jbc.R116.755694_bib91","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1128\/MCB.01146-12","article-title":"Monoubiquitination of filamin B regulates vascular endothelial growth factor-mediated trafficking of histone deacetylase 7","volume":"33","author":"Su","year":"2013","journal-title":"Mol. Cell. Biol"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820348675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820348675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.R116.755694","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,18]],"date-time":"2021-12-18T13:13:16Z","timestamp":1639833196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820348675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":91,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0021925820348675"],"URL":"https:\/\/doi.org\/10.1074\/jbc.r116.755694","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Emerging Role of Non-traditional Ubiquitination in Oncogenic Pathways","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.R116.755694","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}]}}